2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
142
Gastrointestinal Stromal Tumors
71
Leukemia
69
Leukemia, Myeloid, Chronic-Phase
50
Precursor Cell Lymphoblastic Leukemia-Lymphoma
43
Blast Crisis
22
Neoplasms
15
Brain Neoplasms
15
Philadelphia Chromosome
14
Melanoma
13
Sarcoma
12
Neoplasm Metastasis
12
Leukemia, Myeloid, Acute
12
Leukemia, Myeloid, Accelerated Phase
12
Glioblastoma
12
Lung Neoplasms
11
Prostatic Neoplasms
10
Leukemia, Myeloid
9
Gliosarcoma
9
Glioma
8
Breast Neoplasms
8
Primary Myelofibrosis
7
Leukemia, Myelomonocytic, Chronic
7
Central Nervous System Neoplasms
7
Astrocytoma
7
Recurrence
6
Polycythemia Vera
6
Ovarian Neoplasms
6
Oligodendroglioma
6
Myeloproliferative Disorders
6
Interventions
pembrolizumab
163
Carboplatin
146
Paclitaxel
125
Cyclophosphamide
94
130-nm albumin-bound paclitaxel
66
Capecitabine
64
Gemcitabine
54
Doxorubicin
50
Albumin-Bound Paclitaxel
45
Taxes
42
atezolizumab
41
Cisplatin
39
sacituzumab govitecan
34
Nivolumab
34
olaparib
32
Epirubicin
32
Specimen Handling
28
Docetaxel
28
eribulin
27
Bevacizumab
26
durvalumab
25
Drug Therapy
25
Biopsy
24
camrelizumab
23
Magnetic Resonance Spectroscopy
22
toripalimab
19
Radiotherapy
17
spartalizumab
16
Everolimus
15
veliparib
14
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Triple Negative Breast Neoplasms
×
Imatinib Mesylate
×
Clear all
NCT05722795
2025-07-09
I-CONIC
Vastra Gotaland Region
Phase NA
Recruiting
40 enrolled